Instructions and Disclosures

Inspire – Every Intervention is Progress on a Path to Smoke-Free Living
Time: 1 hour webinar

Overall Purpose:
Through multiple mechanisms, including the judgment of the continuing education (CE) planning group, the Foundation for HealthSMART Consumers has identified a gap in consistency in implementing the Tobacco Use and Dependence Clinical Practice Guideline: 2008 Update. This webinar is designed to increase smoking cessation interventions in retail‐based clinics by providing nurse practitioners and other attending clinicians with training and counseling resources to: inspire the clinician to initiate more conversations on this important topic; facilitate best‐practice patient counseling with tools designed for this point of care; provide information about treatment options and other available resources to support quit attempts.

John R. Delfs, M.D., Senior Fellow, The Foundation for HealthSMART Consumers
Joseph McGovern, Senior Fellow, The Foundation for HealthSMART Consumers

Learning Objectives:
1) Discuss the individual components of evidence-based data on tools available to help patients quit smoking.
2) Describe appropriate timing and the process for patient referrals to physicians.
3) Describe the use, indications, contraindications and patient education associated with replacement therapies and other pharmacotherapy options available for use in smoking cessation treatment plans.

Target Audience: Retail clinicians including physicians, nurses, nurse practitioners and physician assistants.
1) Read all disclosures and information below and confirm that you have reviewed this information.
2) Click the "Next" button to go on to a brief pre-training survey.
3) Click "Next" to go on to the webinar video.
4) Click the video box to view and expand to full screen, as necessary.
5) Click "Next" to go on to post-training survey.
6) Click "Go to CE evaluation" to be redirected to the evaluation and credit award site.
The Foundation for HealthSMART Consumers strives to ensure balance, independence, objectivity and scientific rigor in all of its educational programs. All planners, faculty members, moderators, discussants, panelist and presenters participating in this program have been required to disclose any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of this program. This includes relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is to identify openly any conflict of interest so that the attendees may form their own judgments about the presentation with full disclosure of the facts. In addition, faculty is expected to openly disclose any off-label, experimental and/or investigational uses of drugs or devices in their presentation.

The planners, faculty members, moderators and speakers of this educational activity have disclosed no financial relationship with any commercial entities pertaining to this activity.

This training opportunity is made possible by a grant from the Pfizer Independent Grants for Learning & Change Group. Pfizer had no influence on the planning, implementation, or evaluation of this presentation.

* 1. Have you reviewed all instructions and disclosures presented here?